Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
2017 · Science · 5,249 citations
https://doi.org/10.1126/science.aan3706
M
Marine Fidelle
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
8.0K
Citations
16
h-index
20
i10-index
Marine Fidelle is an academic researcher from Inserm. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Gut microbiota and health & Immune Cell Function and Interaction. The author has an h-index of 16, co-authored 63 publications.
ORCID: 0000-0002-5589-9688Papers by this author
worksKetogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade
2020 · JCI Insight · 497 citations
https://doi.org/10.1172/jci.insight.145207
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
2023 · Science · 195 citations
https://doi.org/10.1126/science.abo2296
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment
2021 · Cell Death and Differentiation · 155 citations
https://doi.org/10.1038/s41418-021-00784-1
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome
2024 · Cell · 142 citations
https://doi.org/10.1016/j.cell.2024.05.029
Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
2020 · Frontiers in Immunology · 77 citations
https://doi.org/10.3389/fimmu.2020.600886
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat